July 23rd 2024
Researchers noted that many dermatologists face mild, non-life-threatening complications during procedures, yet must be prepared for emergencies.
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
The evolution of cosmetic surgery for the common good
February 1st 2002There exists today with both the lay public and some physicians a significantmisunderstanding about who is qualified to perform cosmetic or aestheticsurgical procedures. Perhaps this is the proper time to try and correctsome of the more common misimpressions about this controversy.
Skin substitute may improve post-Mohs appearance
February 1st 2002Chicago - A single application of tissue-engineered, bilayeredskin substitute (Human Skin Substitute, Apligraf) to full-thickness woundscreated from Mohs micrographic or excisional surgery treatment of skin cancersresults in scars slightly more favorable than those healed by secondary-intentionhealing, according to single center study results.